Imara
Latest round
- Series B
Last raised
- Mar 2019
Total raised
- $75M
Investors
- 9
About Imara
Founded in 2016 and based in Massachusetts, US, Imara, Inc. is a biopharmaceutical company that develops novel therapeutics to treat patients suffering from rare cell diseases. The company develops IMR-687, a highly selective and potent small-molecule inhibitor that helps in reducing the red blood cell sickling and blockage of blood vessels.
Who invested in Imara
9 investors across 2 rounds
See all investors in Imara
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Imara
Who invested in Imara?
Imara has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Imara raised?
Imara has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Imara last raise money?
Imara's most recent round on record is a Series B, in Mar 2019.
What does Imara do?
Founded in 2016 and based in Massachusetts, US, Imara, Inc.
Where is Imara headquartered?
Imara is headquartered in Boston, US.
Which VCs invest in companies like Imara?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Imara's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Imara? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.